IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody for Multiple Myeloma: Interm Phase 1 Trial Results and Correlative Biologic and Safety Data
Benson, Don M, Bakan, Courtney E, Padmanaban, Swaminathan, Abonour, Rafat, Suvannasankha, Attaya, Jagannath, Sundar, Chari, Ajai, Clever, David, Kalu, Chidimma, Collins, Shauna, Alghothani, Yousef, Hofmeister, Craig C., Efebera, Yvonne, Blanchet, Stephane, Caligiuri, Michael A., Farag, Sherif
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article